By modulating SIRT3 expression, ZEB1 not only drives aerobic glycolysis but also contributes to the broader metabolic flexibility and survival of pancreatic cancer cells under the hypoxic and nutrient-poor conditions leading to alterations in the tumor microenvironment. This evidence concerns the gene ZEB1 and pancreatic neoplasm.